Cortical Atrophy and White Matter Hyperintensities in HIV: The Hawaii Aging with HIV Cohort Study

Journal of Stroke and Cerebrovascular Diseases

Volumn 17, Issue 4, 2008, Pages 212-217

  McMurtray, Aaron ^a   Nakamoto, Beau ^a,b   Shikuma, Cecelia ^a   Valcour, Victor ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b STRAUB CLINIC AND HOSPITAL   (United States)

Author keywords

aging; human immunodeficiency virus infection; ischemic vascular disease; Leukoaraiosis

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN ISCHEMIA; BRAIN SIZE; COHORT ANALYSIS; DIAGNOSTIC IMAGING; FEMALE; FRONTAL LOBE; GRAY MATTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMAGE ANALYSIS; LEUKOARAIOSIS; LIFESPAN; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; UNITED STATES; WHITE MATTER; WHITE MATTER HYPERINTENSITY;

ADULT; AGED; AGED, 80 AND OVER; AGING; ATROPHY; BRAIN; BRAIN ISCHEMIA; COHORT STUDIES; DISEASE SUSCEPTIBILITY; FEMALE; FRONTAL LOBE; HAWAII; HIV INFECTIONS; HUMANS; HYPERTENSION; INTRACRANIAL ARTERIOSCLEROSIS; LEUKOARAIOSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SMOKING; SURVIVORS;

EID: 45449098878     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2008.02.005     Document Type: Article

References (46)

1. Goodkin K., Wilkie F.L., Concha M., et al. Aging and neuro-AIDS conditions and the changing spectrum of HIV-1 associated morbidity and mortality. J Clin Epidemiol 54 (2001) S35-S43 (suppl)
2. Inzitari D. Leukoaraiosis: An independent risk factor for stroke?. Stroke 34 (2003) 2067-2071
3. Basile A.M., Pantoni L., Pracucci G., et al. Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes: The LADIS (leukoaraiosis and disability in the elderly) study. Cerebrovasc Dis 21 (2006) 315-322
4. Ovbiagele B., and Saver J.L. Cerebral white matter hyperintensities on MRI: Current concepts and therapeutic implications. Cerebrovasc Dis 22 (2006) 83-90
5. Rossi R., Boccardi M., Sabattoli F., et al. Topographic correspondence between white matter hyperintensities and brain atrophy. J Neurol 253 (2006) 919-927
6. DeCarli C., Murphy D.G., Tranh M., et al. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology 45 (1995) 2077-2084
7. Mirsen T.R., Lee D.H., Wong C.J., et al. Clinical correlates of white matter changes on magnetic resonance imaging scans of the brain. Arch Neurol 48 (1991) 1015-1021
8. Ylikoski A., Erkinjuntti T., Raininko R., et al. White matter hyperintensities on MRI in the neurologically nondiseased elderly. Stroke 26 (1995) 1171-1177
9. Boone K.B., Miller B.L., Lesser I.M., et al. Neuropsychological correlates of white-matter lesions in healthy elderly subjects: A threshold effect. Arch Neurol 49 (1992) 549-554
10. Mendez M.F., and Cummings J.L. Dementia: A clinical approach. 3rd edition (2003), Elsevier Science Publishing Company, Philadelphia
11. Longstreth Jr. W.T., Bernick C., Manolio T.A., et al. Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: The cardiovascular health study. Arch Neurol 55 (1998) 1217-1225
12. Vermeer S.E., Den Heijer T., Koudstaal P.J., et al. Rotterdam scan study: Incidence and risk factors of silent brain infarcts in the population-based Rotterdam scan study. Stroke 34 (2003) 392-396
13. Capizzano A.A., Acion L., Bekinschtein T., et al. White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer's disease. J Neurol Neurosurg Psychiatry 75 (2004) 822-827
14. Valcour V., Shikuma C., Shiramizu B., et al. Higher frequency of dementia in older HIV+ individuals: The Hawaii aging with HIV cohort. Neurology 63 (2004) 822-827
15. McMurtray A.M., Nakamoto B., Shikuma C., et al. Small vessel vascular disease in HIV infection: The Hawaii aging with HIV cohort study. Cerebrovasc Dis 24 (2007) 236-241
16. de Leeuw F.-E., de Groot J.C., Achten E., et al. Prevalence of cerebral white matter lesions in elderly people: A population based magnetic resonance imaging study, the Rotterdam scan study. J Neurol Neurosurg Psychiatry 70 (2001) 9-14
17. Members and Collaborators of the Wellcome Department of Imaging Neuroscience. "Statistical Parametric Mapping." Available from: URL:www.fil.ion.ucl.ac.uk/spm. Last accessed April 14, 2008.
18. Good C.D., Johnsrude I.S., Ashburner J., et al. A voxel-based morphometric study of ageing in 465 normal adult human brains. NeuroImage 14 (2001) 21-36
19. Hachinski V.C., Potter P., and Merskey H. Leuko-araiosis. Arch Neurol 44 (1987) 21-23
20. Roman G.C., Erkinjuntti T., Wallin A., et al. Subcortical ischemic vascular dementia. Lancet Neurol 1 (2002) 426-436
21. Chui H.C., Victoroff J.I., Margolin D., et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's disease diagnostic and treatment centers. Neurology 42 (1992) 473-480
22. Roman G.C., Tatemichi T.K., Erkinjuntti T., et al. Vascular dementia: Diagnostic criteria for research studies; report of the NINDS-AIREN international workshop. Neurology 43 (1993) 250-260
23. Hachinski V.C., Lassen N.A., and Marshall J. Multi-infarct dementia: A cause of mental deterioration in the elderly. Lancet 2 (1974) 207-210
24. The World Health Organization. International statistical classification of diseases and related health problems, 1989 rev (1992), World Health Organization, Geneva 311-388
25. Sultzer D.L., Mahler M.E., Cummings J.L., et al. Cortical abnormalities associated with subcortical lesions in vascular dementia: Clinical and positron emission tomographic findings. Arch Neurol 52 (1995) 773-780
26. Takahashi W., Takagi S., Ide M., et al. Reduced cerebral glucose metabolism in subjects with incidental hyperintensities on magnetic resonance imaging. J Neurol Sci 176 (2000) 21-27
27. Wen W., Sachdev P., Shnier R., et al. Effect of white matter hyperintensities on cortical cerebral blood volume using perfusion MRI. NeuroImage 21 (2004) 1350-1356
28. Fazekas F., Schmidt R., Kleinert R., et al. The spectrum of age-associated brain abnormalities: Their measurement and histopathological correlates. J Neural Transm Suppl 53 (1998) 31-39
29. Ozdener H. Molecular mechanisms of HIV-1 associated neurodegeneration. J Biosci 30 (2005) 391-405
30. Tullberg M., Fletcher E., DeCarli C., et al. White matter lesions impair frontal lobe function regardless of their location. Neurology 63 (2004) 246-253
31. De Groot J.C., De Leeuw F.E., Oudkerk M., et al. Cerebral white matter lesions and cognitive function: The Rotterdam scan study. Ann Neurol 47 (2000) 145-151
32. Longstreth Jr. W.T., Manolio T.A., Arnold A., et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: The cardiovascular health study. Stroke 27 (1996) 1274-1282
33. De Groot J.C., De Leeuw F.E., Oudkerk M., et al. Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol 52 (2002) 335-341
34. Harrison M.J., Newman S.P., Hall-Craggs M.A., et al. Evidence of CNS impairment in HIV infection: Clinical, neuropsychological, EEG, and MRI/MRS study. J Neurol Neurosurg Psychiatry 65 (1998) 301-307
35. Aylward E.H., Brettschneider P.D., McArthur J.C., et al. Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia. Am J Psychiatry 152 (1995) 987-994
36. McArthur J.C., Kumar A.J., Johnson D.W., et al. Incidental white matter hyperintensities on magnetic resonance imaging in HIV-1 infection. J Acquir Immune Defic Syndr 3 (1990) 252-259
37. Levin H.S., Williams D.H., Borucki M.J., et al. Magnetic resonance imaging and neuropsychological findings in human immunodeficiency virus infection. J Acquir Immune Defic Syndr 3 (1990) 757-762
38. Dooneief G., Bello J., Todak G., et al. A prospective controlled study of magnetic resonance imaging of the brain in gay men and parenteral drug users with human immunodeficiency virus infection. Arch Neurol 49 (1992) 38-43
39. Moore D.J., Masliah E., Rippeth J.D., et al. Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS 20 (2006) 879-887
40. Wu Y., Storey P., Cohen B.A., et al. Diffusion alterations in corpus callosum of patients with HIV. AJNR Am J Neuroradiol 27 (2006) 656-660
41. Ragin A.B., Wu Y., Storey P., et al. Diffusion tensor imaging of subcortical brain injury in patients infected with human immunodeficiency virus. J Neurovirol 11 (2005) 292-298
42. Cloak C.C., Chang L., and Ernst T. Increased frontal white matter diffusion is associated with glial metabolites and psychomotor slowing in HIV. J Neuroimmunol 157 (2004) 147-152
43. Ragin A.B., Storey P., Cohen B.A., et al. Disease burden in HIV-associated cognitive impairment: A study of whole-brain imaging measures. Neurology 63 (2004) 2293-2297
44. Ragin A.B., Storey P., Cohen B.A., et al. Whole brain diffusion tensor imaging in HIV-associated cognitive impairment. AJNR Am J Neuroradiol 25 (2004) 195-200
45. Thurnher M.M., Schindler E.G., Thurnher S.A., et al. Highly active antiretroviral therapy for patients with AIDS dementia complex: Effect on MR imaging findings and clinical course. AJNR Am J Neuroradiol 21 (2000) 670-678
46. Bartzokis G., Lu P.H., Geschwind D.H., et al. Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: Implications for cognitive decline and dementia. Arch Gen Psychiatry 63 (2006) 63-72